News and Announcements
CAVATAK Immunotherapy Combo shows more Anti-cancer Activity
- Published October 01, 2014 1:49PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ASX and Media Release, 30 September 2014
CAVATAK Immunotherapy Combination Demonstrates Superior Anti-cancer Activity Presented at the European society for medical oncology (ESMO) 2014 Congress
•Preclinical studies show CAVATAK combined with checkpoint inhibitor agents provides significantly greater anti-tumour activity than checkpoint inhibitors alone
•Data suggest an anti-tumour immune response
•Results strengthen CAVATAK ‘s potential role as combination therapy with checkpoint inhibitors, a major new class of anticancer immunotherapies
30 September 2014, Sydney, Australia: Viralytics Limited (ASX:VLA, OTC:VRACY) overnight announced at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid that preclinical studies have generated further evidence of improved CAVATAK anti-cancer activity when used in combination with immune checkpoint inhibitors, a new class of cancer immunotherapies with blockbuster potential. CAVATAK is a proprietary formulation of a common cold virus that hass been shown to preferentially infect and attack cancer cells.
To view the full ASX and Media Release please click here.
Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
Backed By Leading Investment Groups and Family Offices
